Intra-arterial Melphalan for Neurologic Non-Langerhans Cell Histiocytosis-Reference-Cited by-同舟云学术

Intra-arterial Melphalan for Neurologic Non-Langerhans Cell Histiocytosis

Published:2021-05-12 Issue:23 Volume:96 Page:1091-1093
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Francis Jasmine H.^ORCID,Gobin Y. Pierre,Alshiekh Nasany Ruham^ORCID,Knopman Jared,Ulaner Gary A.,Panageas Katherine S.,Hatzoglou Vaios,Salvaggio Kim,Abramson David H.,Patsalides Athos,Diamond Eli L.^ORCID

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Reference6 articles.

1. Efficacy of MEK inhibition in patients with histiocytic neoplasms

2. Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy;Mazor;Neurooncol Adv,2020

3. Topical nitrogen mustard: An effective treatment for cutaneous Langerhans cell histiocytosis

4. Gobin YP . Technique of intra-arterial chemotherapy for retinoblastoma. In: Francis JH , Abramson DH , eds. Advances in Vision Research, Volume I [online]. Springer; 2015:27-36.

5. Intraarterial Chemotherapy for Brain Tumors by Using a Spatial Dose Fractionation Algorithm and Pulsatile Delivery

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocular findings in patients with histiocytosis and association with clinical and molecular features;British Journal of Ophthalmology;2024-05-24

2. Current and future directions in interventional neuro-oncology—are we there yet?;Journal of NeuroInterventional Surgery;2024-04-18

3. Neurological Manifestations of Histiocytic Disorders;Current Neurology and Neuroscience Reports;2023-05-20

4. Treatment-Refractory Nodular Scleritis;JAMA Ophthalmology;2022-11-01

5. Histiocytosis and the nervous system: from diagnosis to targeted therapies;Neuro-Oncology;2021-05-16